TomoTherapy to Present at 2007 Thomas Weisel Partners Annual Healthcare Conference in Boston
MADISON, Wis. – August 27 – TomoTherapy Incorporated (NASDAQ: TTPY) today announced that Fred Robertson, CEO, and Steve Hathaway, CFO, will present at the 2007 Thomas Weisel Partners Annual Healthcare Conference in Boston on Wednesday, September 5, at 10:20 a.m. ET.
A live Webcast of the presentation will be available on the investor relations page of TomoTherapy’s Web site.
About TomoTherapy Incorporated
TomoTherapy Incorporated has developed, manufactures and sells the TomoTherapy® Hi·Art® treatment system, an advanced radiation therapy system for the treatment of a wide variety of cancers. The Hi·Art treatment system combines integrated CT imaging with conformal radiation therapy to deliver sophisticated radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. The company completed its initial public offering in May 2007 and its stock is traded on the NASDAQ Global Market under the symbol TTPY.
27 Aug 2007
